Cited by 352Hormonal and reproductive studiesHypothalamic control of reproductive hormonesSperm and Testicular Function

Testosterone concentrations in diabetic and nondiabetic obese men

Open access
Dhindsa, Sandeep, Miller, Michael G., McWhirter, Cecilia L., Mager, Donald E., Ghanim, Husam, Chaudhuri, Ajay, Dandona, Paresh·2010·Diabetes Care

Abstract

OBJECTIVE: To determine the prevalence of subnormal testosterone concentrations in patients with obesity and with type 2 diabetes in a primary care clinic population. RESEARCH DESIGN AND METHODS: Free testosterone concentrations of 1,849 men (1,451 nondiabetic and 398 diabetic) in the Hypogonadism In Males (HIM) study were analyzed. The HIM study was a U.S.-based cross-sectional study designed to define the prevalence of hypogonadism in men aged >45 years. Free testosterone was measured by equilibrium dialysis. RESULTS: The prevalence of subnormal free testosterone concentrations in lean, overweight, and obese nondiabetic men was 26% (n = 275), 29% (n = 687), and 40% (n = 489), respectively (P < 0.001 for trend), and 44% (n = 36), 44% (n = 135), and 50% (n = 227), respectively, in diabetic men (P = 0.46 for trend within group and P < 0.05 compared with nondiabetic men). The mean free testosterone concentration of diabetic men was significantly lower than that of nondiabetic men. Free testosterone concentrations were negatively and significantly (P < 0.001) related to age (r = -0.37), BMI (r = -0.18), and sex hormone-binding globulin (r = -0.11) in multiple regression analysis. The average decline of free testosterone concentrations was 7.8 pg/ml per decade in nondiabetic men and 8.4 pg/ml per decade in diabetic men. CONCLUSIONS: Forty percent of obese nondiabetic men and 50% of obese diabetic men aged >or=45 years have subnormal free testosterone concentrations. In view of its high prevalence, obesity is probably the condition most frequently associated with subnormal free testosterone concentrations in males. The concomitant presence of diabetes is associated with an additional increase in the prevalence of subnormal free testosterone concentrations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc09-1649

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dhindsa, S., Miller, M. G., McWhirter, C. L., Mager, D. E., Ghanim, H., Chaudhuri, A., & Dandona, P.
Affiliations
  • Kaleida Health (US)
  • Solvay Pharamaceuticals, Marietta, Georgia;
  • University at Buffalo, State University of New York (US)
Corresponding author
Dandona, Paresh
Venue
Diabetes Care
Published
2010-03-03
Volume
33
Issue
6
Pages
1186-1192
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2101310933
Cited by
352
References
24
Citations by year
2026: 12 · 2025: 15 · 2024: 19 · 2023: 14 · 2022: 24 · 2021: 22 · 2020: 29 · 2019: 21 · 2018: 23 · 2017: 31 · 2016: 31 · 2015: 31 · 2014: 22 · 2013: 20 · 2012: 18
FWCI
13.99
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • Sanofi
  • National Institutes of Health (5r01dk069805-04)
  • University at Buffalo
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-069805-01A1, R01-DK069805, R01DK075877)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
Keywords
free testosterone, hypogonadism, obesity, type 2 diabetes, sex hormone-binding globulin, body mass index, age-related testosterone decline
MeSH terms
Aged, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Humans, Male, Middle Aged, Obesity, Testosterone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review